One of the most prominent medical developments in recent years has been the emergence of a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The best known of these drugs is ...
Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt mental health treatment. Read more here.